Pay in 4 interest-free payments of $5.82 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Conze D, Brenner C, Kruger CL
Autism & Mental Health Comorbidities Navigating Perimenopause and Menopause Managing Weight, Health and Wellbeing in General Practice Pharmacogenomics in General Practice New Brain Health Guidelines What GPs Can Do writer Senior Consultant Endocrinologist
Egrifta SV and Egrifta WR are manufactured under standard pharmaceutical quality controls, not compounded in a back room
PMID: 27601965
Research-grade specs Components: GHK-Cu + BPC-157 + TB-500 Total strength: 70 mg per vial Format: Lyophilized powder, single-vial blend CAS Number: N/A (blend) Pathways studied: Matrix remodelling (GHK-Cu), cell migration and signalling (BPC-157, TB-500) Studied applications Multi-pathway combination research Comparative single-compound vs combination studies Copper-peptide and tripeptide comparative research Cytoskeletal and matrix pathway interaction research Quality & trust 99% HPLC purity, third-party tested Mass spectrometry identity confirmation LAL endotoxin testing on every batch Batch-specific Certificate of Analysis included cGMP manufactured in Dallas, Texas (USA) USA same-day shipping (orders before 2pm CT M-F) Free domestic shipping on orders over $200 Storage & handling Store lyophilized vials refrigerated at 28C, protected from light and heat Reconstitute with bacteriostatic water
After incubation in indicated medium for 24 h, the diameter of each cell disc before and after incubation was measured and ratio was calculated
US$ 22.56
US$ 27.70
US$ 23.34
US$ 29.93
